A note to readers and subscribers
Today Grown In is making some changes to our news, reporting and subscription offerings. Before we get to the what, let me explain the why.
Today Grown In is making some changes to our news, reporting and subscription offerings. Before we get to the what, let me explain the why.
Sims says RIV and Scotts are in cannabis for the long haul, and they are working on plans to build out Etain’s position in New York in a big way.
“I sense this shift in the last month where things are drying up, I’m hearing more and more negative sentiment not just from plant touching, but ancillary businesses as well.”
In an interview with Sen. Street last week, he told us the possibility adult use would be legalized by 2024 was, “Very high. Likely.”
The recall impacted about 330,000 units of product valued at about $18 million, according to testimony from the lawsuit.
To better understand what happened, Grown In caught up with activist Zoë Patchell, now that she’s had a few weeks to digest the dramatic letdown.
Just a couple months ago New York was trumpeting plans to give average farmers an opportunity to jump start the state’s cannabis industry. But today, cannabis farmers tell Grown In they are afraid to provide their names for on-the-record comments.
“I don’t think anyone is aware that there are these extensions, everyone is under the impression that we’re locked into this contract long term.”
Assuming there are no further court-mandated delays, Illinois plans to issue dispensary licenses in three waves.
“Most of the cultivators have dispensaries. What value proposition do I have for them?” said one dispensary license owner.